| Torrent Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 17/03/2023 | bse |
| Torrent Pharmaceuticals Ltd USFDA Pre-Approval Inspection Of Oral Oncology Manufacturing Facility Gujarat |
| 17/03/2023 | bse |
| Torrent Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 16/03/2023 | bse |
| Torrent Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 18/02/2023 | bse |
| Torrent Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 15/02/2023 | bse |
| Torrent Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 03/02/2023 | bse |
| Torrent Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| 01/02/2023 | bse |
| Torrent Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 27/01/2023 | bse |
| Torrent Pharmaceuticals Ltd Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter An |
| 25/01/2023 | bse |
| Torrent Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Investor Presentation |
| 25/01/2023 | bse |
